首页> 外国专利> DUAL RELEASE LEVODOPA ETHYL ESTER AND DECARBOXYLASE IN CONTROLLED RELEASE CORE

DUAL RELEASE LEVODOPA ETHYL ESTER AND DECARBOXYLASE IN CONTROLLED RELEASE CORE

机译:受控释放核心中的双重释放左旋多巴乙基酯和去羧酶

摘要

A tablet which comprises: an inner core formulated for controlled release comprising a mixture of (a) a granulated admixture of a decarboxylase inhibitor and a surfactant, and (b) levodopa ethyl ester or a derivative or a pharmaceutically acceptable salt thereof; and an outer layer encapsulating the inner core and formulated for immediate release comprising a mixture of a granulated decarboxylase inhibitor and levodopa ethyl ester or a derivative or a pharmaceutically acceptable salt thereof. The subject invention also encompasses a method of treating patients suffering from Parkinson's disease or related disorders by the administration of the pharmaceutical compositions of the subject invention. Additionally, the subject invention provides methods of manufacturing the tablets of the subject invention.
机译:片剂,其包含:配制为控释的内核,其包含(a)脱羧酶抑制剂和表面活性剂的颗粒状混合物和(b)左旋多巴乙酯或其衍生物或药学上可接受的盐的混合物;包封内核且配制为立即释放的外层,其包含粒状脱羧酶抑制剂和左旋多巴乙酯或其衍生物或药学上可接受的盐的混合物。本发明还包括通过施用本发明的药物组合物来治疗患有帕金森氏病或相关疾病的患者的方法。另外,本发明提供了制备本发明的片剂的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号